Maturity-onset diabetes of the young (MODY) is characterized by autosomal dominant
inheritance, onset before 25 years of age, absence of β-cell autoimmunity, and sustained …

There are two classes of glucose transporters involved in glucose homeostasis in the body,
the facilitated transporters or uniporters (GLUTs) and the active transporters or symporters …

The hepatocyte nuclear factors (HNFs) namely HNF1α/β, FOXA1/2/3, HNF4α/γ and
ONECUT1/2 are expressed in a variety of tissues and organs, including the liver, pancreas …

This Review covers the rationale, physiological consequences and clinical application of
pharmacological sodium–glucose cotransporter 2 (SGLT2) inhibition. In patients with type 2 …

Maturity-onset diabetes of the young (MODY) is a clinically heterogeneous group of
disorders characterized by nonketotic diabetes mellitus, an autosomal dominant mode of …

Maturity-onset diabetes of the young (MODY) is a group of monogenic disorders
characterized by autosomal dominantly inherited non-insulin dependent form of diabetes …

There are three families of glucose transporters in the human genome, SLC2, SLC5 and
SLC50. Here I review the structure and function of the SLC5 and SLC50 genes. The human …

Four members of two glucose transporter families, SGLT1, SGLT2, GLUT1, and GLUT2, are
differentially expressed in the kidney, and three of them have been shown to be necessary …

Maturity‐onset diabetes of the young (MODY) is a monogenic disorder characterized by
autosomal dominant inheritance of young‐onset (typically< 25 years), noninsulin …

Under diabetic conditions, sodium–glucose cotransporter 2 (SGLT2) for glucose uptake in
proximal tubules (PTs) increases, whereas NAD+-dependent protein deacetylase silent …